Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: 3Sbio, Can-Fite, Capricor, Cstone, FSD, Gilead Sciences, Hifibio, Laurent, Revive, Sirtex Medical US, Sound, TLC, Xortx.